中文 | English
Return
Total: 2 , 1/1
Show Home Prev Next End page: GO
Author:(Fen-lai TAN)

1.Phase I trial of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in Chinese patients with non-small cell lung cancer.

Han-ping WANG ; Li ZHANG ; Yin-xiang WANG ; Fen-lai TAN ; Ying XIA ; Guan-jun REN ; Pei HU ; Ji JIANG ; Meng-zhao WANG ; Yi XIAO

Chinese Medical Journal 2011;124(13):1933-1933

2.A summary of the Malaysian Clinical Practice Guidelines on the management of postmenopausal osteoporosis, 2022

Terence Ing WEI ONG ; Lee Ling LIM ; Siew Pheng CHAN ; Winnie Siew SWEE CHEE ; Alan Swee HOCK CH’NG ; Elizabeth GAR MIT CHONG ; Premitha DAMODARAN ; Fen Lee HEW ; Luqman bin IBRAHIM ; Hui Min KHOR ; Pauline Siew MEI LAI ; Joon Kiong LEE ; Ai Lee LIM ; Boon Ping LIM ; Sharmila Sunita PARAMASIVAM ; Jeyakantha RATNASINGAM ; Yew Siong SIOW ; Alexander Tong BOON TAN ; Nagammai THIAGARAJAN ; Swan Sim YEAP

Osteoporosis and Sarcopenia 2023;9(2):60-69

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2 , 1/1 Show Home Prev Next End page: GO